Outcome
    Moderate Evidence

    Black Cohosh for Mood Stabilization

    Mood effects are inconsistent and confounded by symptom relief in menopausal cohorts.

    Overview

    Mood effects are inconsistent and confounded by symptom relief in menopausal cohorts.

    Verdict

    Insufficient evidence

    How It Works

    Proposed 5-HT7 receptor activity could plausibly influence mood alongside thermoregulation.

    Dosing & Protocol

    Typical dose

    Recommended dose
    40-80 mg/day standardised extract - only where mood tracks vasomotor symptoms
    Expected timeframe
    4-12 weeks, indirectly via vasomotor relief

    Protocol

    studied dose
    40-80 mg/day of standardised extract in menopausal women
    evidence note
    Verdict is insufficient - the mood effect disappears once you account for hot flush improvement
    what happened
    A few trials report reduced anxiety and depressive scores, but the effects disappear when vasomotor symptom improvement is controlled for. That points to relief of flushes and disturbed sleep rather than any direct mood action
    who it might suit
    Menopausal women whose low mood clearly follows sleep disruption from night sweats
    if your mood is the primary problem
    Perimenopausal depression is real and treatable - psychological therapy, antidepressants and, in some cases, hormone therapy have proper evidence

    Evidence

    What the studies say

    A few trials report reduced anxiety and depressive scores in menopausal women, but effects disappear when vasomotor symptom improvement is accounted for.

    No studies are yet linked to both Black Cohosh and Mood Stabilization.

    Safety

    Caveats

    Black cohosh has no demonstrated direct antidepressant or anxiolytic effect - do not use it in place of treatment for depression, and seek urgent help for thoughts of self-harm. Rare but serious liver injury has been reported: stop immediately with jaundice, dark urine, abdominal pain or unusual fatigue, and avoid in liver disease. Contraindicated in pregnancy and breastfeeding. Discuss with your oncologist in hormone-sensitive cancer. Do not exceed 6-12 months without review.

    Less likely to help if

    Women with clinical depression or anxiety disorder, and anyone without vasomotor symptoms.

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.